2025 France Allergy Diagnostics Market Revenue Opportunities Report
Description
The 2025 France Allergy Diagnostics Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Diagnostics Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Allergy Diagnostics market in France are Thermo Fisher Scientific Inc., BioMérieux SA, Siemens Healthineers, and Stallergenes Greer. Thermo Fisher Scientific leads globally with its ImmunoCAP™ system, a gold standard in specific IgE allergy testing, holding a significant market share in France as well. BioMérieux SA, headquartered in France, provides advanced automated allergy testing platforms and has strengthened its position through acquisitions of specialized diagnostic firms. Siemens Healthineers also offers a broad range of allergy diagnostic tests and automated solutions widely used in French clinical settings. Stallergenes Greer specializes in allergen immunotherapy and companion diagnostics and has a notable presence in Europe, including France.
These companies drive market growth in France through continuous innovation, expanding their product portfolios with multiplex allergen testing platforms and molecular diagnostics. Thermo Fisher Scientific’s extensive global network helps maintain its strong footprint, while BioMérieux leverages local expertise and recent strategic acquisitions to reinforce its leadership. Siemens Healthineers focuses on integrating allergy testing within broader clinical diagnostics workflows, and Stallergenes Greer is advancing precision medicine approaches in allergy treatment. Together, these firms contribute to the projected growth of the French allergy diagnostics market, expected to reach USD 558.7 million by 2030 with a CAGR of 9.8%.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Diagnostics Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Allergy Diagnostics market in France are Thermo Fisher Scientific Inc., BioMérieux SA, Siemens Healthineers, and Stallergenes Greer. Thermo Fisher Scientific leads globally with its ImmunoCAP™ system, a gold standard in specific IgE allergy testing, holding a significant market share in France as well. BioMérieux SA, headquartered in France, provides advanced automated allergy testing platforms and has strengthened its position through acquisitions of specialized diagnostic firms. Siemens Healthineers also offers a broad range of allergy diagnostic tests and automated solutions widely used in French clinical settings. Stallergenes Greer specializes in allergen immunotherapy and companion diagnostics and has a notable presence in Europe, including France.
These companies drive market growth in France through continuous innovation, expanding their product portfolios with multiplex allergen testing platforms and molecular diagnostics. Thermo Fisher Scientific’s extensive global network helps maintain its strong footprint, while BioMérieux leverages local expertise and recent strategic acquisitions to reinforce its leadership. Siemens Healthineers focuses on integrating allergy testing within broader clinical diagnostics workflows, and Stallergenes Greer is advancing precision medicine approaches in allergy treatment. Together, these firms contribute to the projected growth of the French allergy diagnostics market, expected to reach USD 558.7 million by 2030 with a CAGR of 9.8%.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
